ASX200 rides another wave higher
Tony Sycamore November 10, 2020 2:50 PM
Reports overnight that a vaccine developed by Pfizer and BioTECH was found to prevent more than 90% of symptomatic COVID19 infections, relegated the U.S. election to the back seat, at least for now.
Providing further research confirms the vaccine is safe, the companies will seek emergency use authorisation by year-end, before a potential rollout in 2021. Offshore equity markets for the better part reacted positively. In the interest rate space, U.S. 10yr bond yields rallied 10.5bp, to 0.92%.
The rally in bond yields explaining why the interest rate sensitive NASDAQ bucked the trend to finish the session -2.16% lower. On the other hand, higher yields the catalyst for the European Banks Index to breathe a sigh of relief and finish up over 12% on the day.
A move that is being partially replicated in Australia today. The “Big 4” Australian banks that make up about 20% of the ASX200 are trading ~5.50% higher at the time of writing. Also helping the ASX200, a rise in the NAB business confidence index to its highest level since May 2019 in response to the emergence of Victoria from lockdown and falling COVID19 case numbers.
All of this has provided further support to the idea on the ASX200 contained in our last article here where we suggesting adding to core long ASX200 positions in expectation of a test and break above 6200.
With the break above 6200 now cemented, it's an opportune time to return to the chart of the ASX200 from 2017 to gauge how far the rally can run.
In 2017, after breaking out of the top of a five-month range, the ASX200 rallied almost 5% in just under one month. If similar were to occur in 2020 it would project a move towards 6500 by Mid-December, about the time the Santa Clause rally kicks in!
In a nutshell, providing the ASX200 holds above support, formerly resistance 6200/6150 area, supported by a rotation back into the banks, the prognosis for the ASX200 remains bullish into year-end with potential towards 6500 and then 6800.
Source Tradingview. The figures stated areas of the 10th of November 2020. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.